Terns Pharmaceuticals Inc (TERN)
5.79
+0.08
(+1.40%)
USD |
NASDAQ |
Nov 22, 16:00
5.79
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Price: 5.79 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 5.56 | 5.79 | 5.46 | 5.71 | 1.180M |
| Nov 20, 2024 | 5.88 | 5.92 | 5.56 | 5.60 | 1.236M |
| Nov 19, 2024 | 5.72 | 5.98 | 5.64 | 5.91 | 1.853M |
| Nov 18, 2024 | 6.21 | 6.21 | 5.57 | 5.70 | 2.027M |
| Nov 15, 2024 | 6.51 | 6.51 | 5.88 | 6.17 | 1.694M |
| Nov 14, 2024 | 6.81 | 6.92 | 6.45 | 6.55 | 847812.0 |
| Nov 13, 2024 | 7.33 | 7.53 | 6.66 | 6.78 | 1.888M |
| Nov 12, 2024 | 7.33 | 7.47 | 6.95 | 7.17 | 1.140M |
| Nov 11, 2024 | 7.42 | 7.630 | 7.36 | 7.46 | 1.488M |
| Nov 08, 2024 | 7.09 | 7.465 | 7.02 | 7.30 | 1.444M |
| Nov 07, 2024 | 7.33 | 7.34 | 6.99 | 7.06 | 894844.0 |
| Nov 06, 2024 | 7.35 | 7.49 | 7.19 | 7.24 | 920445.0 |
| Nov 05, 2024 | 7.03 | 7.215 | 6.94 | 7.17 | 807159.0 |
| Nov 04, 2024 | 6.83 | 7.345 | 6.70 | 7.10 | 1.204M |
| Nov 01, 2024 | 6.91 | 7.10 | 6.79 | 6.94 | 893817.0 |
| Oct 31, 2024 | 7.04 | 7.04 | 6.68 | 6.86 | 1.247M |
| Oct 30, 2024 | 6.81 | 7.17 | 6.49 | 6.89 | 1.543M |
| Oct 29, 2024 | 6.50 | 6.89 | 6.40 | 6.88 | 1.298M |
| Oct 28, 2024 | 6.75 | 6.877 | 6.49 | 6.51 | 1.906M |
| Oct 25, 2024 | 6.77 | 6.94 | 6.65 | 6.67 | 1.554M |
| Oct 24, 2024 | 7.00 | 7.17 | 6.715 | 6.75 | 2.227M |
| Oct 23, 2024 | 7.48 | 7.51 | 6.99 | 6.99 | 1.465M |
| Oct 22, 2024 | 7.19 | 7.59 | 7.19 | 7.50 | 897679.0 |
| Oct 21, 2024 | 7.36 | 7.47 | 7.19 | 7.24 | 1.037M |
| Oct 18, 2024 | 7.52 | 7.73 | 7.36 | 7.41 | 1.120M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.50
Minimum
May 11 2022
27.25
Maximum
Mar 19 2021
8.130
Average
7.05
Median
Oct 13 2022
Price Benchmarks
| Eli Lilly and Co | 747.82 |
| Viking Therapeutics Inc | 52.62 |
| Biomarin Pharmaceutical Inc | 64.25 |
| Elite Pharmaceuticals Inc | 0.6168 |
| Verrica Pharmaceuticals Inc | 1.00 |
Price Related Metrics
| Price to Book Value | 1.349 |
| Earnings Yield | -20.38% |
| Market Cap | 491.80M |